Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
Go back to Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.53 +0.07 (2.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.46 | 52 Week High | $3.64 | |||
| Open | $2.50 | 52 Week Low | $0.14 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $0.00 | |||
| Volume | 56,691 | |||||

